KLKB1 and cancer: We therefore hypothesize that KLKB1-mediated reduction of scuPAR as identified in this study may play an important role in scuPAR-associated diseases, such as prostate (10) and breast (9) cancers, epilepsy (11), cardiovascular disease (12), and FSGS (24).